Hints and tips:
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...ULA has stockpiled two years’ worth of RD180s for launches – and could switch more launches from the Atlas V to its more old-fashioned but wholly US-sourced Delta rockets....
International Edition